GLP-1 medicines have changed how people talk about weight. Millions now use drugs like semaglutide and tirzepatide, and the number on the scale drops fast for many of them. Yet weight is only one signal. Metabolic health is about how your body handles sugar, fat and energy every day, and a lower weight does not guarantee healthy numbers on the inside.
The gap is large. A 2022 analysis of US national data found that only 6.8% of adults had optimal cardiometabolic health across weight, blood sugar, blood lipids, blood pressure and heart disease [1]. Most adults fell short in at least one area.
This guide looks past kilograms. You will learn:
This article is for information only. If you take a GLP-1 medicine or manage a metabolic condition, talk to your doctor before you change your diet or add a supplement.
Metabolic health means your blood sugar, blood fats, blood pressure and waist size sit in healthy ranges without medication. It describes how well your body turns food into energy and stores the rest.
Your weight tells you how much you carry. It does not tell you where fat sits, how much muscle you have, or how your blood vessels cope. Two people with the same weight can have very different results on a blood test.
That is why doctors look at a cluster of measurements. When three or more of them fall outside healthy ranges, clinicians call it metabolic syndrome. International heart and diabetes organisations agreed on a shared set of five risk factors in 2009 [2], and the markers table below uses them.
Poor metabolic health is often silent. Most signs show up on a tape measure, a blood pressure cuff or a blood test, not in how you feel.
If one or more of these apply, ask your doctor for a full check. Early changes are easier to reverse.
Five markers define metabolic health in most clinical guidelines. Two more add useful detail. Ask your doctor for these at your next check-up.
|
Marker |
What it shows |
Common risk threshold |
|---|---|---|
|
Fasting blood glucose |
Sugar in your blood after an overnight fast |
5.6 mmol/L (100 mg/dL) or higher |
|
HbA1c |
Your average blood sugar over about 3 months |
5.7% (39 mmol/mol) or higher signals prediabetes |
|
Triglycerides |
Fat carried in your blood after you eat and store energy |
1.7 mmol/L (150 mg/dL) or higher |
|
HDL cholesterol |
The particles that carry cholesterol back to the liver |
Below 1.0 mmol/L in men, below 1.3 mmol/L in women |
|
Blood pressure |
Force on your artery walls |
130/85 mmHg or higher |
|
Waist circumference |
A proxy for visceral fat |
94 cm or more in European men, 80 cm or more in European women |
|
LDL and oxidized LDL |
Cholesterol particles; the oxidized form drives plaque |
LDL targets depend on your overall risk |
The glucose, lipid, blood pressure and waist thresholds follow the joint international definition of metabolic syndrome [2]. The HbA1c range follows the American Diabetes Association [3]. Your doctor may use different targets based on your history.
Fasting glucose gives a single snapshot. HbA1c shows the trend over weeks. Insulin sensitivity tells you how hard your body works to keep glucose in range. If your pancreas must release more and more insulin, your glucose can look normal for years before it rises.
High triglycerides with low HDL is a common pattern in insulin resistance. Many doctors read the two together. A falling triglyceride level is one of the first changes people see when their metabolism improves.
LDL carries cholesterol to your tissues. When LDL particles react with free radicals, they become oxidized. Oxidized LDL is taken up by cells in the artery wall, and this process plays a part in plaque formation. Standard blood tests report LDL, but not oxidized LDL. Research studies often measure both.
Blood pressure reflects the health of your blood vessels. Waist size is a simple way to estimate visceral fat. Measure it at the level of your belly button, after you breathe out.
GLP-1, short for glucagon-like peptide-1, is a hormone your gut makes every time you eat. GLP-1 medicines are built to copy it. To understand the drugs, start with the hormone.
Special cells in your intestine, called L-cells, release GLP-1 when food reaches them [4]. The hormone sends signals to your pancreas, your stomach and your brain. Your body breaks it down within minutes, so its effect is short and tied to each meal [4].
GLP-1 has four main jobs after a meal [4]:
GLP-1 medicines resist that fast breakdown. They stay active for hours or days, which makes the effects much stronger and longer than your own hormone can produce.
Your gut is where GLP-1 starts, so gut health and metabolic health are closely linked. The trillions of microbes in your gut, your gut microbiome, affect how you process food, store fat and handle blood sugar. Researchers now see the microbiome as a factor in metabolic health, although most findings still show links rather than proof of cause [5].
One link is better understood. Gut microbes ferment fibre into short-chain fatty acids. In human colon cells, one of these acids, propionate, triggered the release of GLP-1 [6]. In a 24-week trial, overweight adults who took a fibre built to release propionate in the colon gained less weight and less abdominal fat than a control group [6].
So what? What you feed your gut microbes may shape your own GLP-1 response. Our article on gut health explains how your gut and your wider health connect.
GLP-1 drugs do more than lower weight. Many people also see better blood sugar, lower blood pressure and lower triglycerides. That is why doctors now talk about GLP-1 and metabolic health together.
These are real gains. They also leave three questions open.
Fast weight loss takes some muscle with it. In a STEP 1 subgroup scanned with DXA, lean mass made up close to 40% of the weight lost [7]. Lean mass includes more than muscle, but the trend matters. Muscle clears glucose from your blood. Less muscle can mean less metabolic reserve as you age.
In the STEP 1 extension, people who stopped semaglutide regained about two-thirds of the weight they had lost within a year [9]. Most of their cardiometabolic improvements moved back toward where they started. Habits built during treatment are what you keep when treatment ends.
GLP-1 drugs act mainly through appetite, insulin release and slower stomach emptying. Oxidative stress, inflammation, the quality of your diet and your fitness level are separate levers. Losing weight often improves them. It does not replace them.
So what? Use the scale as one data point. Track your blood results, protect your muscle and build habits that last beyond the prescription.
Two processes run in the background of most metabolic problems. Neither shows up on a scale, and neither is part of a standard blood test.
Your cells make free radicals, also called reactive oxygen species, as they turn food into energy. Your antioxidant defences normally keep them in check. Oxidative stress is what happens when free radicals outpace those defences. They then damage fats, proteins and DNA.
Researchers measure this damage with markers like malondialdehyde and isoprostanes. Both come from oxidized fats. Excess calories, high blood sugar and visceral fat all raise free radical production.
Oxidative stress also affects how your cells respond to insulin. In a study of cell models and obese mice, higher levels of reactive oxygen species triggered insulin resistance, and lowering them improved insulin sensitivity [10]. This was lab research, not a human trial. It helps explain why scientists study oxidative stress as a part of metabolic health.
Your immune system and your metabolism work closely together. When fat tissue grows, especially around your organs, it releases signals that keep your immune system switched on at a low level. This chronic inflammation affects metabolism and is linked to obesity, type 2 diabetes and heart disease [11].
Doctors measure it with high-sensitivity C-reactive protein, or hs-CRP. A level above 3 mg/L points to higher cardiovascular risk. Learn more on our anti-inflammatory benefits page.
Your body makes its own antioxidant enzymes, and it also takes antioxidants from food. Colourful vegetables, berries, herbs, olive oil and algae all supply them. Carotenoids, the pigments that make foods red, orange and yellow, are one group researchers study closely.
Not all antioxidants work the same way. Some protect the watery parts of cells, some protect fats, and a few cover both. Our guide to the most potent antioxidant compares them.
So what? Weight loss lowers some of this background load. Food quality, activity and sleep matter too.
The basics have the strongest evidence. They work with or without medication, and they keep working after treatment ends.
There is no single metabolic health diet. The patterns with the best evidence share a few traits. They are built on whole foods, rich in fibre and plants, with enough protein and few ultra-processed foods.
Aim for at least 25 g of fibre a day. Increase it slowly and drink enough water.
Your own GLP-1 response is far weaker than a GLP-1 drug. Still, the food you eat and the order you eat it in can raise it.
These studies were small and short, and most involved people with type 2 diabetes. The approach is simple and low-risk, so it is easy to try at home.
GLP-1 drugs cut your appetite, so you eat less of everything. That includes protein, fibre, vitamins and minerals. In 2025, four US nutrition and obesity societies published joint advice on nutrition during GLP-1 treatment [16]. Their main concerns were stomach side effects, nutrient gaps from eating less, and loss of muscle and bone [16].
The joint advice also recommends support from a registered dietitian during treatment [16]. If you can, book a session when you start.
No supplement has been shown to match the effect of a GLP-1 medicine. Products sold as natural GLP-1 supplements or GLP-1 boosters usually contain fibres, plant extracts or probiotics. Some of these ingredients may nudge your own GLP-1 release. None act like a drug that stays active for days.
The evidence behind these claims is often thin. Even in the propionate study described above, the effect came from a fibre designed in a lab to release propionate in the colon, tested against a standard fibre [6]. The 2025 joint nutrition advice lists the dietary modulation of your own GLP-1 as an area that still needs more research [16].
Supplements cannot replace diet, activity, sleep or medication. Some have human research behind them for specific markers, but effects are usually modest. Treat them as a possible addition to a healthy routine, and check with your doctor first. The rest of this article looks at one of them, astaxanthin, and what the human research does and does not show.
Astaxanthin has been tested in randomised, placebo-controlled human trials on blood lipids, oxidative stress, body fat and fat use during exercise. Across these studies, the strongest and most consistent results appear in blood fats and oxidative stress markers. Astaxanthin research is a separate field from GLP-1 research, and no study has tested the two together.
Astaxanthin is a red carotenoid made by the microalga Haematococcus pluvialis. It sits across the full width of cell membranes, which lets it neutralise free radicals on both the inner and outer surface. That position is why researchers study it in conditions linked to oxidative stress.
|
Study |
Who took part |
Dose and length |
What the researchers reported |
|---|---|---|---|
|
Ciaraldi et al., 2023 [17] |
34 adults with prediabetes and raised blood lipids |
12 mg a day, 24 weeks |
Lower LDL and total cholesterol; lower fibrinogen and fetuin-A; a trend toward better insulin action that did not reach significance |
|
Mashhadi et al., 2018 [18] |
44 adults with type 2 diabetes |
8 mg a day, 8 weeks |
Higher adiponectin; lower visceral fat, triglycerides, fructosamine and systolic blood pressure |
|
Choi et al., 2011 [19] |
27 adults with overweight or obesity |
20 mg a day, 12 weeks |
Lower LDL and ApoB; lower malondialdehyde and isoprostanes; higher antioxidant capacity |
|
Choi et al., 2011 [20] |
23 adults with overweight or obesity |
5 or 20 mg a day, 3 weeks |
Lower lipid peroxidation markers; higher superoxide dismutase activity |
|
Yoshida et al., 2010 [21] |
61 adults with mildly raised triglycerides |
6, 12 or 18 mg a day, 12 weeks |
Lower triglycerides at 12 and 18 mg; higher HDL at 6 and 12 mg; higher adiponectin |
|
Saeidi et al., 2023 [22] |
68 men with obesity |
20 mg a day, 12 weeks, with or without training |
Better lipid profile and body composition; largest change when astaxanthin was combined with training |
Blood fats show the clearest results. A 2024 meta-analysis pooled the controlled trials and found that astaxanthin, compared with placebo [23]:
The single trials point the same way. In adults with mildly raised triglycerides, 12 and 18 mg a day lowered triglycerides, and 6 and 12 mg a day raised HDL [21]. In adults with prediabetes and raised lipids, 12 mg a day for 24 weeks lowered LDL by 0.33 mmol/L, along with total cholesterol and markers of cardiovascular risk [17].
Several trials looked at fat stores and how the body burns fat. In adults with type 2 diabetes, 8 mg a day for 8 weeks reduced visceral fat and raised adiponectin, a hormone made by fat tissue that supports insulin sensitivity [18]. In men with obesity, 20 mg a day combined with training reduced body fat percentage more than training alone [22].
A 2026 crossover trial in 20 active women found that 12 mg a day for 2 weeks shifted the body toward burning more fat during moderate cycling [25]. Earlier studies in men gave mixed results, so this is an area to watch. Read more in our guide to astaxanthin and fat metabolism.
In adults with type 2 diabetes, astaxanthin lowered fructosamine, a marker of blood sugar over 2 to 3 weeks [18]. In adults with prediabetes, insulin action trended toward improvement over 24 weeks [17]. Pooled data show a drop in fasting insulin [23] and in fasting glucose in type 2 diabetes [24]. Blood sugar is a newer focus than lipids, and larger trials will show how strong these effects are.
The oxidative stress results are the largest in size. In adults with overweight or obesity, 3 weeks of astaxanthin lowered malondialdehyde by about 35% and isoprostanes by about 65% compared with baseline, while the activity of the antioxidant enzyme superoxide dismutase rose by about 190% [20]. A 12-week placebo-controlled trial confirmed lower oxidation markers and higher antioxidant capacity [19].
Research on astaxanthin and gut health is at the lab stage, but the early findings are promising. In a model that simulates the human colon, astaxanthin increased beneficial bacteria and the production of short-chain fatty acids [26]. In mice on a high-fat diet, an astaxanthin ester protected the gut barrier and increased beneficial bacteria such as Akkermansia and Lactobacillus [27]. Human trials on the microbiome are the next step.
Astaxanthin is fat-soluble, so take it with a meal that contains fat. It supports a healthy routine and does not replace medication. If you take any prescription medicine, check with your doctor or pharmacist first.
Human trials can only be compared when the ingredient is consistent. Natural astaxanthin varies in purity and stability depending on how the algae are grown.
axabio® grows Haematococcus pluvialis in a patented 4th-generation flat-panel photobioreactor in Hemiksem, Belgium. The closed system controls light, temperature and nutrients for each batch. The result is natural astaxanthin built for purity and stability, from the same strain in the same conditions every time. In 2026, axabio® became the first natural astaxanthin producer certified as a B Corporation, recognised for lower energy and water use relative to the purity achieved.
For you, this means fewer variables. When you choose a supplement, look for the algae source, the production method and third-party testing on the label. Our guide to the four generations of astaxanthin production explains the differences in detail.
GLP-1 drugs have made weight loss more reachable for many people. Metabolic health asks a wider question. How do your blood sugar, blood fats, blood pressure, waist and muscle look today?
Astaxanthin stands out among the compounds researchers study in this field, with controlled human trials showing better blood fats and lower oxidative stress, and early work on fat use and the gut. Explore the science in the axabio® Knowledge Hub, and talk to your doctor about the markers that matter for you.